SEC Filing 4: G1 Therapeutics, Inc.
December 5, 2017 9:17am EST
Source: SEC (Index ) via Sqoop
Form 4
Reporting Person: MedImmune Ventures, Inc.
| Transaction | Security | Shares | (Exercise) Price | Value | Owned After |
|---|---|---|---|---|---|
| Sale (S) | Common Stock, $0.0001 par value per share | 133,906 | $19.7500 | $2,644,644 | 3,150,630 |